Givinostat (hydrochloride) |
199657-29-9 |
199657-29-9 |
SulfoniuM, (4-hydroxyphenyl)Methyl[(2-Methylphenyl)Methyl]-, (OC-6-11)-hexafluoroantiMonate(1-) (1:1) |
(4-羟苯基)甲基(2-甲基苄基)硫鎓六氟锑酸盐 |
141651-31-2 |
SGI-1027 |
SGI-1027 |
1020149-73-8 |
2,6-dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide |
GDC-046;GDC 046 |
1258292-64-6 |
T-3775440 hydrochloride |
T-3775440盐酸盐 |
1422535-52-1 |
LY900009 |
LY900009 |
209984-68-9 |
8-(2-amino-3-chloro-5-(1-methyl-1H-indazol-5-yl)pyridin-4-yl)-2,8-diazaspiro[4.5]decan-1-one |
CCT251921 |
1607837-31-9 |
[2-[[5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4-(trifluoromethoxy)phenyl]boronic acid |
SX-682 |
1648843-04-2 |
FT-113 |
FT113 |
1630808-89-7 |
6-(4-amino-2,6-dichlorophenoxy)-4-isopropylpyridazin-3(2H)-one(WXG00197) |
6-(4-氨基-2,6-二氯苯氧基)-4-异丙基哒嗪-3(2H)-酮 |
920509-28-0 |
A-381393 |
A-381393 |
726174-00-1 |
Copanlisib |
Copanlisib |
1402152-13-9 |
S49076 HCl |
5MG |
1265966-31-1 |
L-765,314 |
L-765314 |
189349-50-6 |
RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
1423186-80-4 |
ERK5-IN-2 |
ERK5-IN-2 |
1888305-96-1 |
9H-Purin-6-aMine, 9-(1-Methylethyl)-N-[[3-(trifluoroMethyl)phenyl]Methyl]- |
9H-Purin-6-aMine, 9-(1-Methylethyl)-N-[[3-(trifluoroMethyl)phenyl]Methyl]- |
1353867-91-0 |
N-Me-L-Ala-maytansinol |
N-Me-L-Ala-maytansinol |
77668-69-0 |
m-tolyl 5-chloro-2-(ethylsulfonyl)pyrimidine-4-carboxylate |
SBI-115; SBI 115; SBI115 |
882366-16-7 |
(R)-3-Boc-aminocyclohexanone |
R-3-BOC-氨基环己酮 |
1383797-87-2 |